
RILAX
Investment Thesis & Opportunity
The Investment Thesis is to disrupt the large, but generic, mindfulness app market by offering an AI-driven, data-personalized solution. The opportunity is to capture a significant share of the rapidly growing global mindfulness meditation apps market, which was valued at $2.08 billion in 2020 and is projected to reach $6.48 billion by 2027 at 17.6% CAGR. RILAX positions itself as a precise tool for organizations and individuals facing stress-related challenges, a niche neglected by competitors like Calm and Headspace. The technology's pre-emptive stress detection is a key feature that competitors lack, allowing RILAX users to experience a projected 40% reduction in stress and a 30% improvement in productivity.
Business Model, Market Opportunity, & Strategy
RILAX operates on a Freemium Model, offering essential features at no cost while driving revenue through a Premium Subscription model priced at $10/month for full access to the AI-driven personalized features. Revenue is also generated through Corporate Wellness Partnerships and Referral-based growth. The Marketing Strategy is digital and partnership-focused, involving SEO/PPC to dominate search results and collaborating with HR leaders to integrate RILAX into employee wellness programs. Key milestones include launching the MVP in May 2025, achieving 15,000 monthly active users by the end of 2025, and pursuing Global Expansion in 2027.
Financial Performance, Terms, & Target Returns
RILAX is currently seeking an initial Angel round of £500,000, with a £2,000,000 pre-money valuation. This funding totals £2,500,000. The allocation of the initial £500,000 prioritizes R&D (55%) and Go-to-Market (20%). The company projects a rapid path to profitability, reaching the break-even point in 2026 after initial losses in the first two years. Projected annual revenue growth is steep, climbing to £25M by 2027 and £75M by 2028, while maintaining a steady 70% Gross Margin.
Impact Measurement, Management, & SDG Alignment
Management Team & Corporate Governance
Risk Factors & Exit Strategy
No Exit Strategy is provided.




